|
|
 |
|
Viewing report
|
|
|
|
Biotechnology Valuation: An Introductory Guide
John Wiley and Sons Ltd, Nov 2008, Pages: 216
Biotechnology is a forward-looking, cash-hungry industry. It takes £500-800m and years to develop a drug which then might not come to market, so bio-tech and pharma companies are constantly looking to all areas of the finance industry for funding. Their assets are often highly intangible (intellectual property) and, because they are so forward-looking, there is little current concrete information available for the investor other than retrospective insights into previous projects. It is a high-risk business, but one which can give massive returns. Investors need to be able to evaluate such companies properly in order to make proper business decisions about their investment.
The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips. It will look at the European industry and its evolvement, and draw parallels and probe the similarities and differences between that and the US. The book looks at the various companies which make up the biotech industry (therapeutic = drug development - most difficult for the non-expert; life sciences - tools and kits; and the medical technology company - devices such as hips, implants) and gives tools for the investor to properly evaluate them. A CD will provide Excel examples with specific relevance to evaluating drug development.
This is the first book to provide a simple and practical means of valuing biotech companies.
The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Biotechnology in India
Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (August 2008)
Asia Pacific Biotechnology Market (2007-2010)
Vitacon Drug Valuation Model™
Global Biotechnology Markets Trends
The North America Biotechnology Sectors : A Company and Industry Analysis (August 2007)
The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles
Indian Biotechnology Market Outlook (2006)
The Future of White Biotechnology in China
Biotechnology Sector
Marine Biotechnology - Global Strategic Business Report
The Europe Biotechnology Sectors : A Company and Industry Analysis (April 2007)
|
|
|
|
